Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

633 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Disease progression of human SOD1 (G93A) transgenic ALS model rats.
Matsumoto A, Okada Y, Nakamichi M, Nakamura M, Toyama Y, Sobue G, Nagai M, Aoki M, Itoyama Y, Okano H. Matsumoto A, et al. Among authors: itoyama y. J Neurosci Res. 2006 Jan;83(1):119-33. doi: 10.1002/jnr.20708. J Neurosci Res. 2006. PMID: 16342121
Development of a high-throughput microarray-based resequencing system for neurological disorders and its application to molecular genetics of amyotrophic lateral sclerosis.
Takahashi Y, Seki N, Ishiura H, Mitsui J, Matsukawa T, Kishino A, Onodera O, Aoki M, Shimozawa N, Murayama S, Itoyama Y, Suzuki Y, Sobue G, Nishizawa M, Goto J, Tsuji S. Takahashi Y, et al. Among authors: itoyama y. Arch Neurol. 2008 Oct;65(10):1326-32. doi: 10.1001/archneur.65.10.1326. Arch Neurol. 2008. PMID: 18852346
[Late-onset nonketotic hyperglycinemia: a case report].
Hasegawa T, Shiga Y, Matsumoto A, Takeda A, Itoyama Y. Hasegawa T, et al. Among authors: itoyama y. No To Shinkei. 2002 Dec;54(12):1068-72. No To Shinkei. 2002. PMID: 12599524 Review. Japanese.
Heterogeneity and continuum of multiple sclerosis phenotypes in Japanese according to the results of the fourth nationwide survey.
Ishizu T, Kira J, Osoegawa M, Fukazawa T, Kikuchi S, Fujihara K, Matsui M, Kohriyama T, Sobue G, Yamamura T, Itoyama Y, Saida T, Sakata K; Research Committee of Neuroimmunological Diseases. Ishizu T, et al. Among authors: itoyama y. J Neurol Sci. 2009 May 15;280(1-2):22-8. doi: 10.1016/j.jns.2009.01.008. Epub 2009 Feb 7. J Neurol Sci. 2009. PMID: 19201428
Clinical features and a mutation with late onset of limb girdle muscular dystrophy 2B.
Takahashi T, Aoki M, Suzuki N, Tateyama M, Yaginuma C, Sato H, Hayasaka M, Sugawara H, Ito M, Abe-Kondo E, Shimakura N, Ibi T, Kuru S, Wakayama T, Sobue G, Fujii N, Saito T, Matsumura T, Funakawa I, Mukai E, Kawanami T, Morita M, Yamazaki M, Hasegawa T, Shimizu J, Tsuji S, Kuzuhara S, Tanaka H, Yoshioka M, Konno H, Onodera H, Itoyama Y. Takahashi T, et al. Among authors: itoyama y. J Neurol Neurosurg Psychiatry. 2013 Apr;84(4):433-40. doi: 10.1136/jnnp-2011-301339. Epub 2012 Dec 15. J Neurol Neurosurg Psychiatry. 2013. PMID: 23243261 Free PMC article.
Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis.
Touil H, Kobert A, Lebeurrier N, Rieger A, Saikali P, Lambert C, Fawaz L, Moore CS, Prat A, Gommerman J, Antel JP, Itoyama Y, Nakashima I, Bar-Or A; Canadian B Cell Team in MS. Touil H, et al. Among authors: itoyama y. J Neuroinflammation. 2018 Apr 19;15(1):114. doi: 10.1186/s12974-018-1136-2. J Neuroinflammation. 2018. PMID: 29673365 Free PMC article.
[Nationwide questionnaire study in "the Model Core Curriculum" and current status for the undergraduate education in neurology].
Sasaki H, Arimura K, Itoyama Y, Kwak S, Kira J, Nakashima K, Amano T, Inoue K, Uozumi T, Kohara N, Tsuji S, Tamagawa A, Toyoshima I, Mizutani T, Yoshii F, Sobue G, Shimizu T; Subcommittee of the Japanese Society of Neurology for Undergraduate Education. Sasaki H, et al. Among authors: itoyama y. Rinsho Shinkeigaku. 2008 Aug;48(8):556-62. doi: 10.5692/clinicalneurol.48.556. Rinsho Shinkeigaku. 2008. PMID: 18939474 Japanese.
Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients.
Abe K, Itoyama Y, Sobue G, Tsuji S, Aoki M, Doyu M, Hamada C, Kondo K, Yoneoka T, Akimoto M, Yoshino H; Edaravone ALS Study Group. Abe K, et al. Among authors: itoyama y. Amyotroph Lateral Scler Frontotemporal Degener. 2014 Dec;15(7-8):610-7. doi: 10.3109/21678421.2014.959024. Epub 2014 Oct 6. Amyotroph Lateral Scler Frontotemporal Degener. 2014. PMID: 25286015 Free PMC article. Clinical Trial.
633 results